Nathan S. Kline

ORCID: 0000-0003-0454-4999
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Attention Deficit Hyperactivity Disorder
  • Mental Health and Psychiatry
  • Treatment of Major Depression
  • Child and Adolescent Psychosocial and Emotional Development
  • Bipolar Disorder and Treatment
  • Pharmaceutical studies and practices
  • Mental Health Treatment and Access
  • Electroconvulsive Therapy Studies
  • Neuropeptides and Animal Physiology
  • Psychotherapy Techniques and Applications
  • Neurotransmitter Receptor Influence on Behavior
  • Autism Spectrum Disorder Research
  • Diet and metabolism studies
  • Tryptophan and brain disorders
  • Psychiatric care and mental health services
  • Pharmaceutical Economics and Policy
  • Epilepsy research and treatment
  • Psychedelics and Drug Studies
  • Neuroscience, Education and Cognitive Function
  • Behavioral and Psychological Studies
  • Resilience and Mental Health
  • Pain Mechanisms and Treatments
  • Pharmacological Effects and Toxicity Studies
  • Phenothiazines and Benzothiazines Synthesis and Activities

Fordham University
2024

Historical Society of Rockland County
1978-2022

Nathan Kline Institute for Psychiatric Research
1981-2018

New York University
2007-2010

Western Kentucky University
1995

University of California, San Diego
1993

Lancet Laboratories
1983

St Bartholomew's Hospital
1982

Maudsley Hospital
1982

New York State Office of Mental Health
1979

10.1111/j.1749-6632.1954.tb45922.x article EN Annals of the New York Academy of Sciences 1954-04-01

Recent and exciting research in animals has described endogenous polypeptides, endorphins, which many biological respects resemble opiate agonists.<sup>1-3</sup>While behavioral effects are under intense investigation, the of pure endorphins man require specific testing. The effect antagonists schizophrenic patients<sup>4</sup>are some dispute, but a recent doubleblind study revealed no effects.<sup>5</sup>Thus, direct measures injected relevant to understanding their man. Accordingly, when...

10.1001/archpsyc.1977.01770210125012 article EN Archives of General Psychiatry 1977-09-01

10.7326/0003-4819-92-4-585_4 article EN Annals of Internal Medicine 1980-04-01

10.1097/00000441-197407000-00002 article EN The American Journal of the Medical Sciences 1974-07-01

This author's inspection of the literature on oral dyskinesia following prolonged phenothiazine administration reveals that many cases reported do not meet criteria necessary to establish existence a tardive, irreversible syndrome. He concludes incidence this side effect has been misrepresented and it should be regarded as significant danger in treatment.

10.1176/ajp.124.8s.48 article EN American Journal of Psychiatry 1968-02-01

The authors conducted single- and double-blind studies of the responses 7 chronic male schizophrenic patients to 10 mg naloxone. BPRS ratings were made before 6 hours after injection; ACTH blood levels determined 1 1/2 injection. Statistically significant improvement psychotic behavior occurred hours. greatest in patient who showed most pronounced diurnal variation levels, there was no had changes. Prolactin plasma following endorphin injections apparently dose-dependent peaked at...

10.1176/ajp.136.6.762 article EN American Journal of Psychiatry 1979-06-01

10.1176/ajp.112.9.684 article EN American Journal of Psychiatry 1956-03-01

There is a dearth of literature on the effects neuroleptics in older schizophrenia patients. In this article, we review available and present findings from our own studies. Neuroleptics are effective treatment late-life schizophrenia, although patients generally need lower dosages than younger subjects. Neuroleptics, however, carry relatively high risk side such as tardive dyskinesia (TD) middle-aged elderly By end 1 year prospective longitudinal study neuroleptic treatment, found 26 percent...

10.1093/schbul/19.4.817 article EN Schizophrenia Bulletin 1993-01-01

10.1111/j.1749-6632.1955.tb42454.x article EN Annals of the New York Academy of Sciences 1955-04-01

Abstract A group of gibbons (Hylobates lar) has been maintained in the seminatural, designed environment Hall island, Bermuda, since 1970, demonstrating feasability long term, experimental studies animals instrumented with intracerebral electrodes and a shoulder harness to carry radio stimulators telemetric units for recording mobility. Observations spontaneous behavior were synchronized using 5 sec units, broadcast experimenters field. The following conclusions are derived from our study:...

10.1080/09291017809359634 article EN Journal of Interdisiplinary Cycle Research 1978-11-01

10.1001/jama.1964.03070210047009 article EN JAMA 1964-11-23

Fluphenazine enanthate is a useful and potent medication with clinically effective range of 10 to 20 days from single depot injection. The usefulness this preparation in preventing the hospitalization or re-hospitalization extremely psychotic patients illustrated discussed.

10.1176/ajp.120.10.1012 article EN American Journal of Psychiatry 1964-04-01

MORE HUMAN SUFFERING has resulted from depression than any other single disease. Despite their relatively recent introduction into medical practice, antidepressants are used in the treatment of over 4 million patients a year United States. Unfortunately our inability to detect certain types or get all obvious cases come for therapy contribute 20,000<i>known</i>suicides US, and at least twice that number who go undetected. Two persons this country estimated have made one suicidal...

10.1001/jama.1964.03070210038007 article EN JAMA 1964-11-23

10.1176/ajp.119.9.809 article EN American Journal of Psychiatry 1963-03-01

1. In a series of 2,100 consecutive admissions to the Veterans Administration Hospital, Lyons, N. J., 72% schizophrenics were photographed in standardized somatotype position shortly after admission. 2. These photographs rated by Dr. William H. Sheldon, who had no knowledge as diagnosis, disposition, or any other pertinent information about patients. Since these patients included much larger made up psychoneurotics, neurological cases, and nonneuropsychiatric patients, addition...

10.1176/ajp.107.6.434 article EN American Journal of Psychiatry 1950-12-01
Coming Soon ...